发明名称 |
METHODS AND COMPOSITIONS FOR GENERATING CHONDROCYTE LINEAGE CELLS AND/OR CARTILAGE LIKE TISSUE |
摘要 |
A method for generating chondrocytes and/or cartilage, optionally articular like non-hypertrophic chondrocyte cells and/or cartilage like tissue and/or hypertrophic chondrocyte like cells and/or cartilage like tissue, the method comprising: a. culturing a primitive streak-like mesoderm population, optionally a CD56+, PDGFRalpha+ KDR-primitive streak-like mesoderm population, with a paraxial mesoderm specifying cocktail comprising: i. a FGF agonist; ii. a BMP inhibitor; optionally Noggin, LDN-193189, Dorsomorphin; and iii. optionally one or more of a TGFbeta inhibitor, optionally SB431524; and a Wnt inhibitor, optionally DKK1, IWP2, or XAV939; to specify a paraxial mesoderm population expressing cell surface CD73, CD105 and/or PDGFR-beta; b. generating a chondrocyte precursor population comprising: i. culturing the paraxial mesoderm population expressing CD73, CD105 and/or PDGFR-beta at a high cell density optionally in serum free or serum containing media; ii. culturing the high cell density CD73+, CD105+ and/or PDGFRbeta+ paraxial mesoderm population with a TGFbeta3 agonist in serum free media to produce a high cell density Sox9+, collagen 2+ chondrocyte precursor population; and c. either i. culturing the high cell density Sox9+, collagen 2+ chondrocyte precursor population with the TGFbeta3 agonist for an extended period of time to produce an articular like non-hypertrophic chondrocyte cells and/or cartilage like tissue; or ii. culturing the high cell density Sox9+ collagen2+ chondrocyte precursor population with a BMP4 agonist for an extended period of time to produce a hypertrophic chondrocyte like cells and/or cartilage like tissue. |
申请公布号 |
US2016038544(A1) |
申请公布日期 |
2016.02.11 |
申请号 |
US201414782070 |
申请日期 |
2014.04.02 |
申请人 |
UNIVERSITY HEALTH NETWORK |
发明人 |
KELLER Gordon;CRAFT April M. |
分类号 |
A61K35/32;C12N5/077;G01N33/50 |
主分类号 |
A61K35/32 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for generating chondrocytes and/or cartilage, optionally articular like non-hypertrophic chondrocyte cells and/or cartilage like tissue and/or hypertrophic chondrocyte like cells and/or cartilage like tissue, the method comprising:
a. culturing a primitive streak-like mesoderm population, optionally a CD56+ and PDGFRalpha+ primitive streak-like mesoderm population, with a paraxial mesoderm specifying cocktail comprising:
i. a FGF agonist;ii. a BMP inhibitor; optionally Noggin, LDN-193189, Dorsomorphin; andiii. optionally one or more of a TGFbeta inhibitor, optionally SB431542; and a Wnt inhibitor, optionally DKK1, IWP2, or XAV939;to specify a paraxial mesoderm population expressing cell surface CD73, CD105 and/or PDGFR-beta; b. generating a chondrocyte precursor population comprising:
i. culturing the paraxial mesoderm population expressing CD73, CD105 and/or PDGFR-beta at a high cell density optionally in serum free or serum containing media;ii. culturing the high cell density CD73+, CD105+ and/or PDGFRbeta+ paraxial mesoderm population with a TGFbeta agonist in serum free media to produce a high cell density Sox9+, collagen 2+ chondrocyte precursor population; and c. either
i. culturing the high cell density Sox9+, collagen 2+ chondrocyte precursor population with the TGFbeta agonist for an extended period of time to produce an articular like non-hypertrophic chondrocyte cells and/or cartilage like tissue; orii. culturing the high cell density Sox9+ collagen2+ chondrocyte precursor population with a BMP4 agonist for an extended period of time to produce a hypertrophic chondrocyte like cells and/or cartilage like tissue. |
地址 |
Toronto CA |